Showing results (41-50 of 144) with videos related to
Sort By:
Pageof 15
European Journal of Cancer & Clinical Oncology|February 1, 1988
Relationship between the structure of analogues of amsacrine and their degree of cross-resistance to adriamycin-resistant P388 leukaemia cellsB C Baguley, G J FinlayCancer Chemotherapy and Pharmacology|May 10, 2000
Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugsG J Finlay, B C BaguleyJournal of the National Cancer Institute|April 6, 1988
Derivatives of amsacrine: determinants required for high activity against Lewis lung carcinomaB C Baguley, G J FinlayEuropean Journal of Cancer & Clinical Oncology|February 1, 1989
Selectivity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitroG J Finlay, B C BaguleyEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase IIG J Finlay, B C BaguleyEuropean Journal of Immunology|August 1, 1979
Some limits to post-antigen generation of diversity: failure to detect variants in clones of hapten-specific antibody-forming cells (AFC) developing in culture from direct AFC-progenitor B cellsK Shortman, M Howard, B L Pike, et al.The American Journal of Anatomy|July 1, 1984
T-cell development in the absence of a thymus: the number, the phenotype, and the functional capacity of T lymphocytes in nude miceW F Chen, R Scollay, K Shortman, et al.The Journal of Experimental Medicine|October 1, 1979
Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokinesJ Watson, S Gillis, J Marbrook, et al.Clinical and Diagnostic Laboratory Immunology|November 1, 1996
Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligandR Ameratunga, J McKee, J French, et al.Oncology Research|January 1, 1993
A comparison of the effects of aphidicolin and other inhibitors on topoisomerase II-directed cytotoxic drugsA Haldane, G J Finlay, B C BaguleyPageof 15